Beneficial effects of a soy-based dietary supplement on lipid levels and cardiovascular risk markers in type 2 diabetic subjects.
about
Effect of Replacing Animal Protein with Plant Protein on Glycemic Control in Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsSoy and fish as features of the Japanese diet and cardiovascular disease risks.Does genotype and equol-production status affect response to isoflavones? Data from a pan-European study on the effects of isoflavones on cardiovascular risk markers in post-menopausal women.Effects of soybean supplementation on blood glucose, plasma lipid levels, and erythrocyte antioxidant enzyme activity in type 2 diabetes mellitus patients.Soybean isoflavone extract improves glucose tolerance and raises the survival rate in streptozotocin-induced diabetic rats.Effects of native banana starch supplementation on body weight and insulin sensitivity in obese type 2 diabeticsSoy protein reduces serum cholesterol by both intrinsic and food displacement mechanisms.Plant and animal protein intake and its association with overweight and obesity among the Belgian population.Critical review of health effects of soyabean phyto-oestrogens in post-menopausal women.Taking a low glycemic index multi-nutrient supplement as breakfast improves glycemic control in patients with type 2 diabetes mellitus: a randomized controlled trial.Role of phytoestrogens in prevention and management of type 2 diabetes.Novel soy germ pasta improves endothelial function, blood pressure, and oxidative stress in patients with type 2 diabetes.The effects of soy protein on chronic kidney disease: a meta-analysis of randomized controlled trials.Protein intake and blood pressure in cardiovascular disease.Carbohydrate and fiber recommendations for individuals with diabetes: a quantitative assessment and meta-analysis of the evidence.Macronutrients, food groups, and eating patterns in the management of diabetes: a systematic review of the literature, 2010Can stevioside in combination with a soy-based dietary supplement be a new useful treatment of type 2 diabetes? An in vivo study in the diabetic goto-kakizaki rat.Altered distribution of regulatory lymphocytes by oral administration of soy-extracts exerts a hepatoprotective effect alleviating immune mediated liver injury, non-alcoholic steatohepatitis and insulin resistance.The effect of soy or isoflavones on homocysteine levels: a meta-analysis of randomised controlled trials.Dietary protein type and cardiovascular disease risk factors.Effect of soy proteins Vs soy isoflavones on lipid profile in postmenopausal womenAnti-diabetic functions of soy isoflavone genistein: mechanisms underlying its effects on pancreatic β-cell function.Effects of soy protein and isoflavones on insulin resistance and adiponectin in male monkeys.Dietary phyto-oestrogens: molecular mechanisms, bioavailability and importance to menopausal health.Review article: novel methods for the treatment of non-alcoholic steatohepatitis - targeting the gut immune system to decrease the systemic inflammatory response without immune suppression.Soy protein effects on serum lipoproteins: a quality assessment and meta-analysis of randomized, controlled studies.Dietary protein intake and blood pressure: a meta-analysis of randomized controlled trials.Antidiabetic potential of commonly consumed legumes: a review.Iron binding capacity of dephytinised soy protein isolate hydrolysate as influenced by the degree of hydrolysis and enzyme typeEffect of soybean protein on blood pressure in postmenopausal women: a meta-analysis of randomized controlled trials.Soyfood consumption and risk of glycosuria: a cross-sectional study within the Shanghai Women's Health Study.Oral Co-administration of Soy-derived Extracts with Alcohol or with Sugar-sweetened Beverages Exerts Liver and Sugar Protective Effects.Consumption, perceptions and knowledge of soy among adults with type 2 diabetes.Soya protein does not affect glycaemic control in adults with type 2 diabetes.A novel soy-based meal replacement formula for weight loss among obese individuals: a randomized controlled clinical trial.Soy product and isoflavone intakes are associated with a lower risk of type 2 diabetes in overweight Japanese women.Renal protection by a soy diet in obese Zucker rats is associated with restoration of nitric oxide generation.Long-term efficacy of soy-based meal replacements vs an individualized diet plan in obese type II DM patients: relative effects on weight loss, metabolic parameters, and C-reactive protein.Effects of soy supplementation on blood lipids and arterial function in hypercholesterolaemic subjects.Effects of soy bean on serum paraoxonase 1 activity and lipoproteins in hyperlipidemic postmenopausal women.
P2860
Q28084072-42FF50E5-0329-4501-ADF4-FCFA63CAB2E9Q30377127-6440344C-1F86-4969-9E6F-0B9613976BE7Q31030851-DB9ED91E-6485-4B48-8F81-6C10C7D18146Q33621988-21ACEB3E-8D96-44E6-87C2-4EA3B358EB75Q33767569-7F6526FF-9935-4606-946C-2E6BABC47C64Q33965753-5914027F-CB8E-4E30-A426-0394034C2E04Q34143385-FB39A067-E558-4D78-B67C-17C24A002F52Q34153992-2206B189-7ACB-4000-978D-E81F26B4C3BFQ34564536-011EC543-DA93-496C-9FF3-795967E7B5B1Q34775039-36071F13-8E1F-4CA3-B0D2-576FC9ADF962Q35179232-8AF791C7-03C2-491F-B9FC-C62967D87A0EQ35179942-2A1815AA-3F02-4125-98FD-896485B36753Q35190066-EF1BCC98-4A86-4734-83AB-51335267BECEQ35542203-AC6F6899-DCD6-4A56-97FA-8229BF204FF1Q35667078-DDA4E6A8-4A7F-4DD1-B1AF-46AC253C37EBQ35688317-F51E37C5-2543-4C89-9FE3-438787D377FCQ35688751-EB79596C-1CFA-42D1-B661-A7B4FD235C7CQ35783896-A06BBA08-41CE-44E7-AAF6-E6EAD8DDF7C7Q36026664-B2A652B2-6FC9-44F8-9AB6-1877FC9F0D28Q36050074-18D3C24C-E18A-49A2-B5B0-48E14B02F5F4Q36263155-57B1E134-21FB-4AAC-9B4F-B86A7C5CC3BFQ36918173-3E4CE549-BB4A-417C-8A3E-84558F1C4AA0Q36943591-3B8C508D-05C6-4D47-B18D-0ECC67783B90Q37350043-5DCEF76F-FA94-4611-A541-B67F93D9FF0EQ37563673-F8301C9F-D35E-4F80-8E29-6ECD0932A186Q37897811-3D37DD61-9477-4AFC-B8EB-FEFB461D340AQ38049305-BB6F3B64-0814-4CAF-A57F-3CEEB6279031Q38164806-4E79C950-4229-4054-BE59-E8671D165D10Q39181824-61C92A5D-55CB-4797-A431-52E3985C6C4EQ39413234-F8A07711-FE63-4805-ABFA-3C9130D1006CQ39679670-6B3CCBA0-1458-45D4-B8D3-96BEA0A6E0FAQ41706852-A7BB6FFD-00EA-4A9F-9606-1AFDD1EF5AC2Q43261389-0C137974-DC14-4BC5-8DB9-C8508F950958Q43286317-8AFB7254-4E91-44ED-ADDC-3104E02E8BBCQ44407011-E373D812-FD1D-4167-B795-FF1BF48E470AQ44738039-016A27C8-7D39-491E-9A02-5B527EA86BE9Q45029526-EF084F92-61EE-4502-968E-697F4284DE0DQ45240497-FE3B2592-5776-4552-9E2B-0A394464B5C6Q46496036-6198E662-D87A-4B30-A817-82FB416867C7Q46496378-B16DFD04-176B-46DA-9534-E4D3D06BBF65
P2860
Beneficial effects of a soy-based dietary supplement on lipid levels and cardiovascular risk markers in type 2 diabetic subjects.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Beneficial effects of a soy-ba ...... s in type 2 diabetic subjects.
@ast
Beneficial effects of a soy-ba ...... s in type 2 diabetic subjects.
@en
type
label
Beneficial effects of a soy-ba ...... s in type 2 diabetic subjects.
@ast
Beneficial effects of a soy-ba ...... s in type 2 diabetic subjects.
@en
prefLabel
Beneficial effects of a soy-ba ...... s in type 2 diabetic subjects.
@ast
Beneficial effects of a soy-ba ...... s in type 2 diabetic subjects.
@en
P2093
P356
P1433
P1476
Beneficial effects of a soy-ba ...... s in type 2 diabetic subjects.
@en
P2093
Carstensen M
Hermansen K
Søndergaard M
P304
P356
10.2337/DIACARE.24.2.228
P407
P577
2001-02-01T00:00:00Z